HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 81246986913

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81246986913 and manufactured by ORTHO CLINICAL DIAGNOSTICS. The registration is held by ORTHO CLINICAL DIAGNÓSTICS DO BRASIL PRODUTOS PARA SAÚDE LTDA with validity until Jun 09, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81246986913
2 Related Devices
Registration Details
ANVISA Registration Number: 81246986913
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

VITROS Immunodiagnostic Products CMV IgG Reagent and Calibrator
Risk Class IV

Registration Details

81246986913

25351456456202457

21921393000146

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

Jun 09, 2025

09/06/2035

09/18/2025 19:00:01

VITROS Immunodiagnostic Products CMV IgG Reagent and Calibrator
Risk Class IV

Registration Details

81246986913

25351456456202457

21921393000146

Dates and Status

Jun 09, 2025

09/06/2035

09/18/2025 19:00:01